Lori Ann Heitkamp

Title: Lori Ann Heitkamp: Innovator in Antigen-Binding Proteins

Introduction

Lori Ann Heitkamp is a notable inventor based in Minneapolis, MN (US). She has made significant contributions to the field of biotechnology, particularly in the development of binding proteins that target human CD30. Her work has implications for various medical applications, showcasing her innovative spirit and dedication to advancing science.

Latest Patents

Lori Ann Heitkamp holds a patent for "Human CD30-specific binding proteins and uses thereof." This patent relates to antigen-binding affinity reagents for an analyte-of-interest. The disclosure provides novel binding proteins, including derivatives and fragments, that specifically target human CD30, highlighting her expertise in antibody development.

Career Highlights

Heitkamp is associated with R & D Systems, Inc., where she has been instrumental in research and development efforts. Her work at the company reflects her commitment to innovation in the biotechnology sector.

Collaborations

She has collaborated with notable colleagues, including Cyrus B Munshi and Kerri Ann Bostrom, contributing to a dynamic research environment that fosters creativity and scientific advancement.

Conclusion

Lori Ann Heitkamp's contributions to the field of antigen-binding proteins exemplify her role as an innovator in biotechnology. Her patent and collaborative efforts underscore her impact on medical research and development.